Skip to main content

Table 1 Baseline characteristics of patients included in the study

From: Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

 

Active ILIT

Placebo ILIT

Number of participants

21

15

Age (y), median (range)

30 (20–52)

30 (20–54)

Gender (male vs. female)

13:8

9:6

Allergen-specific IgE (kU/L)

4.4 – 100.0

0.47 – 78.6

Birch vs. grass vaccination

8:13

6:8

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us